Medicine & Life Sciences
Polysaccharides
53%
Blood Platelets
40%
Mucins
39%
defactinib
36%
Non-Small Cell Lung Carcinoma
33%
Pancreatic Neoplasms
32%
Glycosylation
30%
Lung Neoplasms
29%
ramucirumab
27%
atezolizumab
27%
Glomerular Filtration Barrier
26%
Endothelial Cells
26%
Circulating Tumor DNA
24%
pembrolizumab
24%
Lymphangiogenesis
23%
Lenalidomide
22%
Blood Vessels
22%
Mantle-Cell Lymphoma
22%
Adenocarcinoma
21%
DNA Fingerprinting
21%
Lymph
21%
Small Cell Lung Carcinoma
20%
Venules
20%
Dendritic Cells
20%
gemcitabine
19%
Neoplasms
18%
Hemostasis
17%
Podocytes
16%
Cell Communication
16%
Drug Therapy
15%
T-Lymphocytes
14%
Lymphatic Vessels
14%
Fibrosis
12%
Platinum
11%
Breast Neoplasms
10%
N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide
10%
Progression-Free Survival
10%
Lymphatic System
10%
Immunity
9%
Kidney
9%
Recurrence
9%
Tumor Microenvironment
8%
Focal Adhesion Protein-Tyrosine Kinases
8%
Lymph Nodes
8%
Macrophages
8%
Acetylgalactosamine
8%
Therapeutics
8%
Thoracic Duct
7%
Punctures
6%
Survival
6%
Chemical Compounds
O-Glycan
100%
Threonine Residue
23%
N-Acetylgalactosamine
23%
Serine Residue
21%
Mammalian Cell
17%
Glycosylation
17%
Filtration
14%
Peptide
9%
Reduction
7%
Protein
7%
Flow
5%